Interstitial Cystitis A pilot study assessed the safety and efficacy of BPC 157 for interstitial cystitis in 12 women who had not responded to conventional therapies
Findings were categorized into motor symptoms (such as gait disturbances and neuropathy), non-motor symptoms (focusing on cognitive decline), pathophysiological mechanisms (based on molecular pathways, neuropathology, metabolites and genes), and therapeutic implications (Vit B12 supplementation, clinical recommendations)
The same may be true of folic acid, which is commonly taken in supplement form during pregnancy, per a 2022 study published in Advances in Nutrition
View Units PDF Route Subcutaneous (SQ) Usage Duration 5 weeks Based on 10 units SQ once weekly
This product is intended for administration by qualified medical and aesthetic practitioners as part of supervised wellness or treatment protocols